Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2014, Vol. 10 ›› Issue (06): 757 -761. doi: 10.3877/cma.j.issn.1673-5250.2014.06.013

Special Issue:

Original Article

Comparative Study of Evaluating Indicators for Cervical Cancer Mass Screening

Lili Han1, Tongxiang Zhao2, Xiaohong Deng3()   

  1. 1. Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026 , China
  • Received:2014-05-15 Revised:2014-10-20 Published:2014-12-01
  • Corresponding author: Xiaohong Deng
  • About author:
    (Corresponding author : Deng Xiaohong,Email : )
Objective

To explore the rational and feasible evaluation indicators of mass screening of new-onset cervical cancer.

Methods

A total of 2 092 medical records of new-onset cervical cancer in Beijing from January 2007 to December 2010, as well as cervical cancer incidence and mortality from January 2000 to December 2010 in Beijing were provided by Beijing Office for Cancer Prevention and Control. Meanwhile, the clinical data of mass screening of cervical cancer during the year of 2008 and 2009 were collected from Maternal Child Network Information System. A co-analysis were made retrospectively. The different evaluation indicators (incidence rates, mortality, early stage diagnosis rates, detection rates, participate rates and early diagnosis rates) of cervical cancer screening were compared.

Results

Among 2 092 new-onset cervical cancer patients from January 2007 to December 2010, 1 663 cases (79.49%,1 663/2 092) had a clear clinical stage and 442 cases (26.58%, 442/1 663) were advanced cervical cancer patients. By checking the medical records of advanced cervical cancer of the hospitals and comparing with the data of cervical cancer screening from the year of 2008 and 2009, it showed that 24 cases with advanced cervical cancer participated in the cervical cancer screening, and 5 cases were missed. Those 5 cases mainly concentrated in 4 counties in Beijing. According to the current evaluation indicators of cervical cancer, screening effects of the four counties ranked the forefront among the whole 18 counties.

Conclusions

There are pros and cons between advanced cervical cancer incidence data, incidence rate, mortality, early diagnosis rate, detection rate, participate rate of cervical cancer. But by comparison with the advanced cervical cancer incidence data provided by the hospital medical records and cervical cancer screening data, we can find out misdiagnosed advanced cervical cancer patients, which can evaluate the quality of cervical cancer screening.

表1 2008 – 2009年度北京市各区县宫颈癌筛查参与率、检出率、早期诊断率分布情况
Table 1 The distribution of participate rates, detection rates and early diagnosis rates of 18 counties between the year of 2008 and 2009
表2 北京市各区县宫颈癌筛查效果比较
Table 2 Comparison of the cervical cancer screening effects among different counties in Beijing
图1 北京市宫颈癌发生率和死亡率变化情况(竖线表示2008年与2009年为筛查年度)
Figure 1 Incidence and mortality change of uterine cervical cancer in Beijing (Vertical line means screening year)
[1]
李雪,孔为民,韩超,等.首都医科大学附属北京妇产医院1992 –2011年间宫颈癌发病趋势分析[J/CD].中华妇幼临床医学杂志:电子版,2013,9(3):310–314.
[2]
Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 [J]. Int J Cancer, 2010, 127 (12) : 2893–2917.
[3]
Tay SK, Ngan HY, Chu TY, et al. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan [J]. Vaccine, 2008, 26 (Suppl 12) : M60–M70.
[4]
郑莹.中国女性癌症预防和控制策略[J].中华预防医学杂志,2013, 47(2):101–104.
[5]
董志伟,乔友林.癌症早诊早治工作评价指标的探讨[J].中国肿瘤,2010,19(10):633–638.
[6]
韩历丽,齐庆青,王朝,等.:北京市宫颈癌和乳腺癌筛查现况与结果分析[J].中华健康管理学杂志,2011,5 (5):292–294.
[7]
董志伟,乔友林,王贵齐,等.癌症早诊早治的评价[J].中华肿瘤杂志,2012,34(8):637–639.
[8]
Maree JE, Wright SC. Cervical cancer: does our message promote screening? A pilot study in a South African context [J]. Eur J Oncol Nurs, 2011, 15(2): 118–123.
[9]
尹畅,李会庆,刁玉涛,等.山东省1 970 – 2005年宫颈癌死亡率变化趋势[J].中国卫生统计,2009,26(4):347–349.
[10]
Eduardo C, Sue M, Patticia A, et al. Cervical cancer screening in developing countries: why is it ineffective? The case of Mexico[J]. Arch Med Res, 2009, 30 (3) : 240.
[11]
Anttila A, Ronco G, Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer (EUNICE). Description of the national situation of cervical cancer screening in the member states of the European Union [J]. Eur J Cancer, 2009, 45 (15): 2685–2708.
[12]
van der Aa MA, Schutter EM, Looijen-Salamon M, et al. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001 [J]. Eur J Obstet Gynecol Reprod Bol, 2008, 139(2): 204–209.
[13]
韩历丽,齐庆青,王朝,等.北京市宫颈癌筛查费用分析[J].中华医院管理杂志,2011,27(5):367–368.
[14]
韩历丽,齐庆青,王朝,等.北京市18个区县宫颈癌、乳腺癌检出率比较[J].中国妇幼保健,2011,26(16):2426–2428.
[15]
de Bie RP, Vergers-Spooren HC, Massuger LF, et al. Patients with cervical cancer : why did screening not prevent these cases? [J]. Am J Obstet Gynecol, 2011, 205(1): 64. e1–e7.
[16]
韩历丽,齐庆青,王朝,等.北京市两癌筛查主要问题与经验探讨[J].实用预防医学,2011,18(3):566–568.
[17]
Konno R, Shin HR, Kim YT, et al. Human papillomavirus infection and cervical cancer prevention in Japan and Korea [J]. Vaccine, 2008, 26(Suppl 12): M30–M42.
[18]
王春芳,赵丽君,祁文娟,等.妇科门诊患者子宫颈癌认知度和筛查状况分析[J].中国妇产科临床杂志,2012,13 (2):112–114.
[19]
伍军平,罗新,吴小花.宫颈癌筛查8463例结果分析[J/CD].中华妇幼临床医学杂志:电子版,2011,6(7):197–201.
[20]
杨忠明,丁显平,庞博,等.人乳头瘤病毒DNA联合液基薄层细胞学检测在宫颈癌筛查诊断中的研究[J].成都医学院学报,2011,6(4):320–323.
[1] Sainan Guan, Xi Zhou, Cuiling Jian, Weiqiang Chen, Juan Fu, Changlin Song, Fan Yuan, Erjiao Xu. Value of gastric wall thickness in ultrasonic screening of gastric lesions[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2021, 18(08): 782-787.
[2] Xiaofei Sun, Yiqun Gu, Aichun Wang, Li Wang, Fanfan Meng, Jun Wang, lijuan Lu. Evaluation on cervical intraepithelial neoplasia for patients with cervicitis by p16/Ki-67 double staining[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(06): 418-425.
[3] Fei Li, Dawei Zhang, Yulei Liu, Jiang Xie, Guangfa Zhu. Inflammation indicators and pathogenic bacteria in puerperium patients complicated with bloodstream infection[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2021, 15(04): 243-249.
[4] Yanyu Tang, Xia Tang, Lijuan Li. Clinical analysis of acetylcysteine effervescent tablets combined with tiotropium bromide inhalation in the treatment of patients with chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(03): 335-338.
[5] Yingying Wang, Kana Wang, Sijing Chen, Na Wang, Ying Zheng. Laparoscopic radical trachelectomy for early cervical cancer[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(06): 372-375.
[6] Cankun Zhou, Qingdong Li, Zhuofei Jiang, Lijie Zhao, Yuhua Zheng, Xiaochun Liu, Qinghuang Xie, Xiaobin Huang. Vaginal radical hysterectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(06): 368-371.
[7] Yunyue Liu, Wensheng Fan, Chenglei Gu, Xin Ma, Hongyi Liu, Yuanguang Meng. Da Vinci robot MDT mode total pelvic exenteration in the treatment of advanced cervical cancer: a case report[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2022, 15(04): 249-251.
[8] Ting Zhang, Shanshan Qin, Shengsheng Yu, Juanpeng Yu, Yuchen Song, Yingchun Gao. A novel direct approach to the deep uterine vein in laparoscopic radical hysterectomy[J]. Chinese Journal of Laparoscopic Surgery(Electronic Edition), 2021, 14(06): 363-364.
[9] Mingming Dong, Zhixin Wang, Qian Zhao. Prognostic value of nutritional indicators for patients with hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(01): 117-120.
[10] Jingxiong Hu, Jing Zhou, Qian Huang, Ruiying Ma, Wenguang Peng, Yuesi Zhong. Predictive value of hepatobiliary imaging indexes for liver function in patients with portal hypertension due to post-hepatitis B cirrhosis[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(05): 493-497.
[11] Juan Du, Zhenyu Wei, Qingfeng Liang. Screening of diagnostic parameters and establishment of diagnostic model for meibomian gland dysfunction[J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2021, 11(06): 339-345.
[12] Zhenfei Lin, Shijie Chen. Value of stereotactic puncture drainage in the treatment of basal ganglia cerebral hemorrhage[J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2022, 08(01): 34-38.
[13] Hongjian Duan, Jianhao Zhang, Xinwei Han, Yanping Zhao, Yuhong Hou, Jie Yang, Su Yan, Shengdong Qin. Analysis of individualized interventional treatment of vesicovaginal fistula[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2022, 10(01): 45-49.
[14] Man Yin, Linqing Yang, Yunfei Wang. Diagnostic characteristics of synchronous mucinous metaplasia and neoplasia of the female genital tract and literature review[J]. Chinese Journal of Diagnostics(Electronic Edition), 2022, 10(03): 193-196.
[15] Di Shen, Li Quan, Cunyu Liang, Qi Meng, Yusufu Aibibai·. Study on the correlation between time within the target range of glucose and urinary microalbumin level in patients with type 2 diabetes[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2022, 08(04): 249-255.
Viewed
Full text


Abstract